We are live on ! Find out more
GDRX icon

GoodRx Holdings

168 hedge funds and large institutions have $988M invested in GoodRx Holdings in 2024 Q3 according to their latest regulatory filings, with 38 funds opening new positions, 40 increasing their positions, 46 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

53% more call options, than puts

Call options by funds: $6.04M | Put options by funds: $3.95M

19% more first-time investments, than exits

New positions opened: 38 | Existing positions closed: 32

4.59% more ownership

Funds ownership: 139.73%144.32% (+4.6%)

2% more funds holding

Funds holding: 165168 (+3)

0% more funds holding in top 10

Funds holding in top 10: 33 (0)

4% less capital invested

Capital invested by funds: $1.03B → $988M (-$40.7M)

13% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 46

Holders
168
Holders Change
+3
Holders Change %
+1.82%
% of All Funds
2.41%
Holding in Top 10
3
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
38
Increased
40
Reduced
46
Closed
32
Calls
$6.04M
Puts
$3.95M
Net Calls
+$2.09M
Net Calls Change
+$1.02M
Name Holding Trade Value Shares
Change
Change in
Stake
SIS
151
Strategic Investment Solutions
Illinois
$694
FFWM
152
Future Financial Wealth Management
Ohio
$694 +$785 +100 New
LC
153
Lindbrook Capital
California
$659 -$510 -65 -41%
Northwestern Mutual Wealth Management
154
Northwestern Mutual Wealth Management
Wisconsin
$625
Optiver Holding
155
Optiver Holding
Netherlands
$618 +$699 +89 New
BTI
156
Blue Trust Inc
Georgia
$320 +$322 +41 New
LFG
157
Larson Financial Group
Missouri
$291
RA
158
Rise Advisors
New York
$278
PA
159
Parallel Advisors
California
$257
FDCDDQ
160
Federation des caisses Desjardins du Quebec
Quebec, Canada
$174 +$78 +10 +67%
S
161
SignatureFD
Georgia
$174 +$196 +25 New
CPA
162
Capital Performance Advisors
California
$139 +$157 +20 New
LSA
163
Leonteq Securities AG
Switzerland
$49
JWA
164
JFS Wealth Advisors
Pennsylvania
$42
DPW
165
DiNuzzo Private Wealth
Pennsylvania
$35 -$8 -1 -17%
SIC
166
SJS Investment Consulting
Ohio
$35 -$8 -1 -17%
Schroder Investment Management Group
167
Schroder Investment Management Group
United Kingdom
-$5.35M -685,315 Closed
TI
168
Trexquant Investment
Connecticut
-$3M -384,074 Closed
EIM
169
Essex Investment Management
Massachusetts
-$2.38M -304,770 Closed
AG
170
Algert Global
California
-$1.41M -181,251 Closed
Canada Pension Plan Investment Board
171
Canada Pension Plan Investment Board
Ontario, Canada
-$1.3M -166,142 Closed
SI
172
SQN Investors
California
-$1.1M -140,500 Closed
Voloridge Investment Management
173
Voloridge Investment Management
Florida
-$1.08M -137,974 Closed
Tudor Investment Corp
174
Tudor Investment Corp
Connecticut
-$1.02M -131,277 Closed
ECU
175
Eisler Capital (US)
New York
-$835K -107,108 Closed

GDRX Hedge Fund Activity: Q3 2024 in Review

168 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in GoodRx Holdings (GDRX) for Q3 2024, worth a combined $988M — down 4% from $1.03B a quarter earlier.

Buyers outnumbered sellers: 38 funds opened new GDRX positions and 32 closed out — a net gain of 6 holders — while 40 added to existing stakes and 46 trimmed.

The largest buyer was T. Rowe Price Investment Management, opening a new position worth an estimated $29.9M. The largest seller was Schroder Investment Management Group, exiting entirely with an estimated $5.35M sold.

  • 168 institutional investors held GoodRx Holdings (GDRX) as of Q3 2024, up from 165 in Q2 2024.
  • Funds reported $988M of GoodRx Holdings stock for Q3 2024, down 4% quarter-over-quarter.
  • 38 funds opened new GoodRx Holdings positions in Q3 2024 and 32 closed out, a net change of +6 holders.
  • The largest GoodRx Holdings buyer in Q3 2024 was T. Rowe Price Investment Management, an estimated $29.9M added.
  • The largest GoodRx Holdings seller in Q3 2024 was Schroder Investment Management Group, an estimated $5.35M sold.

Based on aggregated 13F filings for Q3 2024.